A meta-analysis of 21 RCTs found pharmaceutical-grade CBD and THC showed moderate effects for anxiety disorders and PTSD, though evidence remains limited by small samples and heterogeneous designs.
Psychiatrists considering cannabinoid treatments, medical cannabis researchers, patients seeking evidence on cannabis for anxiety.
Pure CBD: moderate effect (SMD -0.61)
What the researchers found
Across 21 placebo-controlled RCTs covering social anxiety, GAD, PTSD, OCD, and Tourette syndrome, pure CBD compounds showed a moderate significant effect (SMD -0.61, 95% CI -1.15 to -0.07). THC-dominant compounds also showed moderate significance (SMD -0.65, 95% CI -1.06 to -0.24). However, CBD-THC mixtures did not reach significance (SMD -0.73, 95% CI -2.00 to 0.55). Pharmaceutical-grade formulations appeared to outperform non-standardized extracts.
Why it matters
This is one of the most comprehensive meta-analyses to date separating cannabinoid types across anxiety-related conditions. The finding that pharmaceutical-grade formulations outperform non-standardized extracts has direct implications for both clinical practice and regulation of medical cannabis for mental health conditions.
The numbers in context
21 RCTs included. Pure CBD: SMD -0.61 (significant). THC-dominant: SMD -0.65 (significant). CBD-THC mixtures: SMD -0.73 (not significant). Conditions: SAD (5 trials), GAD (1), PTSD (7), OCD (1), Tourette (7).
How the study worked
Systematic review and meta-analysis searching PubMed, Embase, PsycInfo, Web of Science, Scielo, and Lilacs for placebo-controlled RCTs. 21 trials included: 5 for social anxiety, 1 GAD, 7 PTSD, 1 OCD, 7 Tourette syndrome. Separate meta-analyses by cannabinoid subtype. Standardized mean differences calculated using Jamovi software.
What this study cannot tell us
Small sample sizes across most included trials. Heterogeneous study designs, doses, and outcome measures. Some conditions had very few trials (1 each for GAD and OCD). Cannot compare conditions head-to-head. THC results driven partly by Tourette syndrome trials which may involve different mechanisms than anxiety.
How to read the evidence
Moderate: rigorous meta-analytic methodology across 21 RCTs, though limited by small trials, heterogeneous designs, and few studies per condition.
When this study was published
2025 study
The bigger picture
The superiority of pure formulations over mixtures challenges the popular "entourage effect" hypothesis for mental health conditions. It suggests that for anxiety and PTSD, precise dosing of specific cannabinoids may matter more than whole-plant approaches, aligning with pharmaceutical rather than dispensary models of care.
Questions still open
- Why do CBD-THC mixtures perform worse than pure compounds for anxiety? Would larger, better-designed trials confirm the moderate effects seen here? Should medical cannabis regulations require pharmaceutical-grade formulations for mental health indications?
Common questions
Does cannabis help with anxiety?
Is CBD or THC better for anxiety disorders?
Read the original research
Effects of Different Cannabinoid Formulations on Anxiety-Related Disorders, and Tourette Syndrome: A Systematic Review and Meta-Analysis.
Cannabis and cannabinoid research, 10(6), 655-672
Citation
Raminelli, Adrieli Oliveira; Simei, João Luís Q; Guimarães, Francisco S; Zuardi, Antônio; Hallak, Jaime Eduardo C; Crippa, José Alexandre; Osório, Flávia de Lima. (2025). Effects of Different Cannabinoid Formulations on Anxiety-Related Disorders, and Tourette Syndrome: A Systematic Review and Meta-Analysis.. Cannabis and cannabinoid research, 10(6), 655-672. https://doi.org/10.1177/25785125251378242
Explore the wider topic
- Weed Withdrawal Anxiety in Public: When Leaving the House Feels Impossible
- The DARE Response to Anxiety for Cannabis Withdrawal
- The Cannabis Withdrawal Anxiety Toolkit: Quick Techniques That Work
- Why Anxiety Gets Worse Before It Gets Better After Quitting Weed
- Breathing Exercises for Weed Withdrawal Anxiety
- Cannabis-Induced Anxiety: When Weed Stops Being Fun
- Does Weed Help or Hurt Anxiety? What Research Actually Shows
- Grounding Techniques for Cannabis Withdrawal: A Practical Toolkit
- Quitting Weed with Health Anxiety: Why Every Symptom Feels Like a Crisis
- How to Manage Anxiety Without Weed: 15 Evidence-Based Alternatives
- Quitting Weed with Anxiety Disorder: A Careful Approach
- Quitting Weed When You're on Anxiety Medication: What to Know
- Self-Medicating Anxiety with Weed: Why It Works Until It Doesn't
- Do I Need Therapy to Quit Weed? When Professional Help Makes Sense
- Weed and Anxiety: The Paradox That Traps People
- The Biphasic Effect: Low-Dose Calms, High-Dose Panics
- Weed and Generalized Anxiety Disorder (GAD): Why It Backfires
- Weed and Panic Attacks: The Connection Nobody Talks About
- Weed and Paranoia: When Cannabis Turns Your Mind Against You
- Weed and Social Anxiety: Why It Feels Like the Only Thing That Helps
- Why Weed Stopped Working for Your Anxiety
- Weed Withdrawal Anxiety: Understanding the Panic and How to Cope
- Weed Withdrawal Panic Attacks at Night: Why They Happen and How to Get Through Them
- Going Back to Work During Weed Withdrawal: Managing Anxiety and Staying Functional
- Withdrawal Anxiety vs Pre-Existing Anxiety: How to Tell the Difference